RVP

Drug Catalog - Product Detail

GUANFACINE HCL TB 1MG 100

NDC Mfr Size Str Form
65162-0711-10 AMNEAL PHARMACEUTICALS 100 1MG TABLET
Product Image

PACKAGE FILES

Package Image
Package Image
Package Image
Generic Name
GUANFACINE
Substance Name
GUANFACINE HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Application Number
ANDA075109
Description
DESCRIPTION Guanfacine hydrochloride, USP is a centrally acting antihypertensive with α 2 -adrenoceptor agonist properties in tablet form for oral administration. The chemical name of guanfacine hydrochloride, USP is N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride and its molecular weight is 282.56. Its structural formula is: Guanfacine hydrochloride, USP is a white to off-white powder; sparingly soluble in water and alcohol and slightly soluble in acetone. Each tablet, for oral administration, contains guanfacine hydrochloride, USP equivalent to 1 mg or 2 mg guanfacine. In addition, each tablet contains the following inactive ingredients: microcrystalline cellulose, pregelatinized starch, and stearic acid. 042bf3b6-figure-01
How Supplied
HOW SUPPLIED Guanfacine tablets, USP are available in 2 tablet strengths of guanfacine (as the hydrochloride salt) as follows: 1 mg: white, oval, flat-faced, beveled-edge tablet with “AN” on one side and “711” on the other side. They are available as follows: Bottles of 30: NDC 65162-711-03 Bottles of 100: NDC 65162-711-10 2 mg: white, oval, flat-faced, beveled-edge tablet with “AN” on one side and “713” on the other side. They are available as follows: Bottles of 30: NDC 65162-713-03 Bottles of 100: NDC 65162-713-10 Bottles of 500: NDC 65162-713-50 Store at 20º to 25 ºC (68 ºF to 77 ºF) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container. Packaged with child-resistant closure. Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807 Rev. 11-2015-00
Indications & Usage
INDICATIONS & USAGE Guanfacine tablets, USP are indicated in the management of hypertension. Guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
Dosage and Administration
DOSAGE & ADMINISTRATION The recommended initial dose of guanfacine tablets, USP when given alone or in combination with another antihypertensive drug is 1 mg daily given at bedtime to minimize somnolence. If after 3 to 4 weeks of therapy 1 mg does not give a satisfactory result, a dose of 2 mg may be given, although most of the effect of guanfacine is seen at 1 mg (see CLINICAL PHARMACOLOGY ). Higher daily doses have been used, but adverse reactions increase significantly with doses above 3 mg/day. The frequency of rebound hypertension is low, but it can occur. When rebound occurs, it does so after 2 to 4 days, which is delayed compared with clonidine hydrochloride. This is consistent with the longer half-life of guanfacine. In most cases, after abrupt withdrawal of guanfacine, blood pressure returns to pretreatment levels slowly (within 2 to 4 days) without ill effects.